Nodular regenerative hyperplasia, portal vein thrombosis, and avascular hip necrosis due to hyperhomocysteinaemia

Buchel, O.; Roskams, T.; van Damme, B.; Nevens, F.; Pirenne, J.; Fevery, J.
July 2005
Gut;Jul2005, Vol. 54 Issue 7, p1021
Academic Journal
A male patient with portal hypertension, portal vein thrombosis, spontaneous splenorenal shunt formation, and encephalopathy, thought to have post-hepatitis B cirrhosis, is described. His condition deteriorated and necessitated liver transplantation. In the explant liver, nodular regenerative hyperplasia with pronounced vascular lesions both in portal venules and in arterioles was found instead of classical cirrhosis. Two years post-transplant he developed bilateral ischaemic femur head necrosis. The three disorders (portal vein thrombosis, nodular regenerative hyperplasia, and ischaemic hip necrosis) seemed to be due to a common vasculopathy induced by hyperhomocyteinaemia. Genetic studies showed that he carried a mutation in the gene encoding for formation of methylenetetrahydrofolate reductase. Treatment with folic acid combined with pyridoxine (vitamin B6) and cyanocobalamin (vitamin B12) normalised his serum homocysteine levels.


Related Articles

  • Cirrhosis: new research provides a basis for rational and targeted treatments. Iredale, John P. // BMJ: British Medical Journal (International Edition);7/19/2003, Vol. 327 Issue 7407, p143 

    The article discusses cirrhosis and the new research that provides a basis for rational and targeted treatments. Liver transplantation and antiviral treatments for hepatitis have improved the outlook for many patients with liver disease. For patients with cirrhosis, new developments herald...

  • A SIGNIFICANT PROPORTION OF MYOFIBROBLASTS ARE OF BONE MARROW ORIGIN IN HUMAN LIVER FIBROSIS. Russo, F. P.; Burra, P.; Rugge, M.; Wright, N. A.; Alison, M. R.; Forbes, S. J. // Gut;Apr2004 Supplement 3, Vol. 53, pA12 

    Myofibroblasts of bone marrow origin have recently been found in a number of parenchymal organs such as the gut and kidney. Authors sought to analyse the origin of myofibroblasts within fibrotic liver in two scenarios: 8 male patients, who received liver transplants from female donors and...

  • Portal vein thrombosis: What is new? del Carmen Manzano-Robleda, María; Barranco-Fragoso, Beatriz; Uribe, Misael; Méndez-Sánchez, Nahum // Annals of Hepatology: Official Journal of the Mexican Associatio;Jan/Feb2015, Vol. 14 Issue 1, p20 

    Portal vein thrombosis (PVT) is one of the most common vascular disorders of the liver with significant morbidity and mortality. Large cohort studies have reported a global prevalence of 1%, but in some risk groups it can be up to 26%. Causes of PVT are cirrhosis, hepatobiliary malignancy,...

  • Evaluation and management of patients with refractory ascites. Senousy, Bahaa Eldeen; Draganov, Peter V.; Riggio, Oliviero // World Journal of Gastroenterology;1/7/2009, Vol. 15 Issue 1, p67 

    Some patients with ascites due to liver cirrhosis become no longer responsive to diuretics. Once other causes of ascites such as portal vein thrombosis, malignancy or infection and non-compliance with medications and low sodium diet have been excluded, the diagnosis of refractory ascites can be...

  • Orthotopic Liver Retransplantation - Case Report. Darabos, Nikica; Patrlj, Leonardo; Kocman, Branislav; Vladic, Ivan; Jadrijevic, Stipislav; Jasprica, Masa // Collegium Antropologicum;Dec2003, Vol. 27 Issue 2, p653 

    We report a case of orthotopic liver retransplantation (OLRT) in a patient who was suffering from rejection and graft failure after orthotopic liver transplantation (OLT). The patient was a 32-year old female who had diagnosed liver lesion - hepatic cirrhosis. Within two months, with presented...

  • New directions in primary biliary cirrhosis. Bateson, M.C. // BMJ: British Medical Journal (International Edition);12/8/90, Vol. 301 Issue 6764, p1290 

    Focuses on the management of primary biliary cirrhosis. Indication of liver transplantation; Application of chlorambucil; Observation of the ursodeoxycholic acid.

  • Continuing Medical Education Questions: August 2015. Lee, Peter; Esfah, Jamak Modaresi; Tian, Chaorui; Wang, Ming-Hsi; DeVault, Kenneth R // American Journal of Gastroenterology;Aug2015, Vol. 110 Issue 8, p1167 

    A quiz concerning severe alcoholic relapse of patients who undergoes liver transplant for alcoholic liver cirrhosis is presented.

  • Association between Portal Vein Thrombosis and Survival in Non-Liver-Transplant Patients with Liver Cirrhosis: A Systematic Review of the Literature. Qi, Xingshun; Dai, Junna; Yang, Man; Ren, Weirong; Jia, Jia; Guo, Xiaozhong // Gastroenterology Research & Practice;2/24/2015, Vol. 2015, p1 

    A systematic review of the literature was performed to analyze the association between portal vein thrombosis (PVT) and survival in non-liver-transplant patients with liver cirrhosis. PubMed, EMBASE, and Cochrane Library databases were searched for all relevant papers which evaluated the...

  • Management of Anticoagulation for Portal Vein Thrombosis in Individuals with Cirrhosis: A Systematic Review. Huard, Geneviève; Bilodeau, Marc // International Journal of Hepatology;2012, p1 

    Non-neoplastic portal vein thrombosis (PVT) is an increasingly recognized complication of liver cirrhosis. It is often diagnosed fortuitously and can be either partial or complete. The clinical significance of PVT is not obvious except in some situations such as when patients are on the waiting...


Read the Article


Sign out of this library

Other Topics